Showing results (271-280 of 357) with videos related to
Sort By:
Pageof 36
CPT: Pharmacometrics & Systems Pharmacology|December 8, 2021
Development of a model-based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophyKarthik Lingineni, Varun Aggarwal, Juan Francisco Morales, et al.Antimicrobial Agents and Chemotherapy|June 6, 2018
Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection ModelG L Drusano, Jenny Myrick, Michael Maynard, et al.Antimicrobial Agents and Chemotherapy|September 26, 2018
Activity of Moxifloxacin against Mycobacterium tuberculosis in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection ModelArnold Louie, Brandon Duncanson, Jenny Myrick, et al.Pharmaceutics|February 25, 2023
Leveraging Physiologically Based Modelling to Provide Insights on the Absorption of Paliperidone Extended-Release Formulation under Fed and Fasting ConditionsSaima Subhani, Viera Lukacova, Chaejin Kim, et al.Cardiovascular Diabetology|December 24, 2025
Glucagon-like peptide-1 receptor agonists and risk for cardiovascular events in older adults treated with levothyroxine: a target trial emulationFanxing Du, Naykky M Singh Ospina, Yishan Chen, et al.Antimicrobial Agents and Chemotherapy|September 9, 2020
Building Optimal Three-Drug Combination Chemotherapy RegimensG L Drusano, Michael N Neely, Sarah Kim, et al.The New Phytologist|January 22, 2019
Protein and metabolite composition of Arabidopsis stress granulesMonika Kosmacz, Michał Gorka, Stephan Schmidt, et al.Archiv Der Pharmazie|March 23, 2023
Optimized synthesis and pharmacological evaluation of HCN channel inhibitor EC18Marius Patberg, Tengiz Oniani, Paul Disse, et al.Journal of Neurology|January 4, 2022
Long-term real-world effectiveness and safety of fingolimod over 5 years in GermanyTjalf Ziemssen, Michael Lang, Stephan Schmidt, et al.Pharmacoepidemiology and Drug Safety|March 7, 2023
High-throughput screening for prescribing cascades among real world statin initiatorsScott M Vouri, Earl J Morris, Marta Walsh, et al.Pageof 36